Image: NASA/GSFC/METI/ERSDAC/JAROS, and U.S./Japan ASTER Science Team | Public domain | via Wikimedia Commons
Dong Fan is a prominent figure in China's healthcare industry, known for chairing Jafron Biomedical, a leading medical device manufacturer. With a source of wealth rooted in medical devices, he has achieved significant success in the healthcare sector. Dong holds advanced degrees from Shanghai University of Finance and Economics and Sun Yat-sen University. As of 2024, he holds a net worth of $1.4 Billion.
Dong Fan's educational background includes a Bachelor of Arts/Science from Shanghai University of Finance and Economics and a Master of Business Administration from Sun Yat-sen University. His strong educational foundation has been a cornerstone of his successful career in the medical device industry.
Dong Fan chairs Jafron Biomedical, which went public in August 2016 on the Shenzhen Stock Exchange. He holds a significant stake in the company, approximately 48%, which has been instrumental in his wealth accumulation. Jafron Biomedical was founded in 1989, initially named Zhuhai Lizhu Medical Biomaterial. It later became Zhuhai Lizhu Medical Biomaterial in 2002 and then changed its name to Jafron Biomedical in 2009. The company's success is a testament to Dong's leadership and strategic vision.
Dong's strategic approach has been critical to Jafron Biomedical's growth. The company's focus on innovation and market expansion has driven its financial performance. The company's IPO in 2016 was a key milestone, raising significant capital for further development. Jafron's revenue and net profit in 2015 were 508.9 million yuan and 200.4 million yuan ($77 million and $30.4 million), up 37% and 25% from the year earlier.
Specific details about Dong Fan’s philanthropic initiatives are not available from the search results.
Founded Zhuhai Lizhu Medical Biomaterial, later renamed Jafron Biomedical.
Jafron Biomedical went public on the Shenzhen Stock Exchange.
